Michael E. Singer

Executive Chairman

Michael Singer has over 25 years of executive leadership with significant operating, healthcare and financial experience.  

As CEO of BrainScope, Michael has guided the company from technology development, clinical studies, product validation, Intellectual Property creation, organizational build, and multiple regulatory clearances to commercial launch of the first FDA-cleared medical device for assessment of the full spectrum of brain injury, including concussion.  Michael also secured significant equity investment and research funding through government and military research contracts.

Before Michael joined BrainScope, he was President of Revolution Health Investments, where he managed its sale to Everyday Health. He was previously the Chief Financial Officer, Executive Vice President of Corporate Development for Data Critical Corporation, a Seattle-based venture-backed medical device company. At Data Critical he was responsible for facilitating the company’s IPO and eventually led the sale of Data Critical to General Electric (GE). He has also worked as an executive at Microsoft Corporation responsible for developing small business and healthcare strategies.  For a decade Michael was a healthcare investment banker and M&A generalist for Wolfensohn & Co., Alex. Brown and Montgomery Securities in New York and San Francisco. He started his career at Union Bank of Switzerland in Zurich.

Michael has served on the Board of Directors of Exact Sciences Corporation (molecular diagnostics), MedEfficiency (medical devices, sold to Derma Sciences), SparkPeople (consumer health), One Reel (entertainment), Data Critical Corporation (medical devices, sold to GE), and the Advisory Board of the Maxwell School of Citizenship and Public Affairs. He holds a Ph.D. from the London School of Economics.